| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Mario Negri Institute for Pharmacological Research,* Milan; and the Department of Internal Medicine, University of Milan, Milan, Italy
C1-inhibitor (C1-INH) is a major regulator of the complement classical pathway. Besides this action, it may also inhibit other related inflammatory systems. We have studied the effect of C1-INH in C57BL/6 mice with focal transient brain ischemia induced by 30 minutes of occlusion of the middle cerebral artery. C1-INH induced a dose-dependent reduction of ischemic volume that, with the dose of 15 U/mouse, reached 10.8% of the volume of saline-treated mice. Four days after ischemia the treated mice had significantly lower general and focal neurological deficit scores. Fluoro-Jade staining, a marker for neuronal degeneration, showed that C1-INH-treated mice had a lower number of degenerating cells. Leukocyte infiltration, as assessed by CD45 immunostaining, was also markedly decreased. We then investigated the response to ischemia in C1q–/– mice. There was a slight, nonsignificant decrease in infarct volume in C1q–/– mice (reduction to 72.3%) compared to wild types. Administration of C1-INH to these mice was still able to reduce the ischemic volume to 31.4%. The study shows that C1-INH has a strong neuroprotective effect on brain ischemia/reperfusion injury and that its action is independent from C1q-mediated activation of classical pathway.
This article has been cited by other articles:
 |
|
 |
|
  E. Shagdarsuren, K. Bidzhekov, Y. Djalali-Talab, E. A. Liehn, M. Hristov, R. A. Matthijsen, W. A. Buurman, A. Zernecke, and C. Weber C1-Esterase Inhibitor Protects Against Neointima Formation After Arterial Injury in Atherosclerosis-Prone Mice Circulation, January 1, 2008; 117(1): 70 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cotena, V. Maina, M. Sironi, B. Bottazzi, P. Jeannin, A. Vecchi, N. Corvaia, M. R. Daha, A. Mantovani, and C. Garlanda Complement Dependent Amplification of the Innate Response to a Cognate Microbial Ligand by the Long Pentraxin PTX3 J. Immunol., November 1, 2007; 179(9): 6311 - 6317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhang, K. Takahashi, E. M. Alicot, T. Vorup-Jensen, B. Kessler, S. Thiel, J. C. Jensenius, R. A. B. Ezekowitz, F. D. Moore, and M. C. Carroll Activation of the Lectin Pathway by Natural IgM in a Model of Ischemia/Reperfusion Injury J. Immunol., October 1, 2006; 177(7): 4727 - 4734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Storini, L. Bergamaschini, R. Gesuete, E. Rossi, D. Maiocchi, and M. G. De Simoni Selective Inhibition of Plasma Kallikrein Protects Brain from Reperfusion Injury J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 849 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Mocco, W. J. Mack, A. F. Ducruet, S. A. Sosunov, M. E. Sughrue, B. G. Hassid, M. N. Nair, I. Laufer, R. J. Komotar, M. Claire, et al. Complement Component C3 Mediates Inflammatory Injury Following Focal Cerebral Ischemia Circ. Res., July 21, 2006; 99(2): 209 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. S. Ten, S. A. Sosunov, S. P. Mazer, R. I. Stark, C. Caspersen, M. E. Sughrue, M. Botto, E. S. Connolly Jr, and D. J. Pinsky C1q-Deficiency Is Neuroprotective Against Hypoxic-Ischemic Brain Injury in Neonatal Mice Stroke, October 1, 2005; 36(10): 2244 - 2250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cai, V. S. Dole, W. Bergmeier, J. Scafidi, H. Feng, D. D. Wagner, and A. E. Davis III A Direct Role for C1 Inhibitor in Regulation of Leukocyte Adhesion J. Immunol., May 15, 2005; 174(10): 6462 - 6466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Troglio, C. Echart, A. Gobbi, T. Pawson, P. G. Pelicci, M. G. De Simoni, and G. Pelicci From The Cover: The Rai (Shc C) adaptor protein regulates the neuronal stress response and protects against cerebral ischemia PNAS, October 26, 2004; 101(43): 15476 - 15481. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
